Preservation of fertility in females treated for cancer
- PMID: 22904668
- PMCID: PMC3421231
- DOI: 10.7150/ijbs.4800
Preservation of fertility in females treated for cancer
Abstract
Advancements of diagnosis and treatment have substantially improved cancer survival rates in the last few decades. The increasing number of survivors focuses attention on long-term effects caused by cancer treatment and its impact on quality of life. Ovarian failure is one of the major sequelae of cytotoxic chemotherapy and/or radiotherapy in female children and reproductive-age women. Oncologists should address the patients about fertility preservation options before therapy. Embryo cryopreservation is the only well-established method for females in preserving fertility; however other strategies including ovarian suppression, ovarian transposition and cryopreservation of oocytes and ovarian tissue are still experimental. Patients need advice and to know which are the most practical options for them. This article reviews the available fertility preservation methods in women, and the related issues including normal physiology of the ovary, effect of anticancer therapy on fertility, role of the oncologist and ethics. We performed a MEDLINE search from 1971 to 2011 in a similar way as Jensen et al. 2011, using the following MeSH terms: antineoplastic agents; ovarian failure; premature; infertility, female; fertility preservation; child and cancer; reproductive technologies, assisted.
Keywords: Cancer patient; Females; Fertility Preservation.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interest exists.
Figures
Similar articles
-
Fertility sparing in cancer patients.Minim Invasive Ther Allied Technol. 2012 Jul;21(4):282-92. doi: 10.3109/13645706.2011.611520. Epub 2011 Sep 16. Minim Invasive Ther Allied Technol. 2012. PMID: 21919808
-
Infertility in reproductive-age female cancer survivors.Cancer. 2015 May 15;121(10):1532-9. doi: 10.1002/cncr.29181. Epub 2015 Feb 3. Cancer. 2015. PMID: 25649243 Review.
-
Toward precision medicine for preserving fertility in cancer patients: existing and emerging fertility preservation options for women.J Gynecol Oncol. 2016 Mar;27(2):e22. doi: 10.3802/jgo.2016.27.e22. J Gynecol Oncol. 2016. PMID: 26768785 Free PMC article. Review.
-
Fertility after breast cancer treatment.Eur J Obstet Gynecol Reprod Biol. 2014 Feb;173:13-8. doi: 10.1016/j.ejogrb.2013.11.009. Epub 2013 Nov 17. Eur J Obstet Gynecol Reprod Biol. 2014. PMID: 24315568 Review.
-
Cancer therapy and reproductive impact.Int J Gynaecol Obstet. 2025 Jun;169(3):891-894. doi: 10.1002/ijgo.16174. Epub 2025 Jan 21. Int J Gynaecol Obstet. 2025. PMID: 39836035 Free PMC article.
Cited by
-
The Effects of Lysophosphatidic Acid on The Incidence of Cell Death in Cultured Vitrified and Non-Vitrified Mouse Ovarian Tissue: Separation of Necrosis and Apoptosis Border.Cell J. 2018 Oct;20(3):403-411. doi: 10.22074/cellj.2018.5180. Epub 2018 May 15. Cell J. 2018. PMID: 29845795 Free PMC article.
-
The Role of lncRNAs in the Protective Action of Tamoxifen on the Ovaries of Tumor-Bearing Rats Receiving Cyclophosphamide.Int J Mol Sci. 2024 Nov 22;25(23):12538. doi: 10.3390/ijms252312538. Int J Mol Sci. 2024. PMID: 39684249 Free PMC article.
-
Ethical, legal, social, and policy issues of ovarian tissue cryopreservation in prepubertal girls: a critical interpretive review.J Assist Reprod Genet. 2024 Apr;41(4):999-1026. doi: 10.1007/s10815-024-03059-z. Epub 2024 Mar 2. J Assist Reprod Genet. 2024. PMID: 38430324 Free PMC article. Review.
-
A Warning Call for Fertility Preservation Methods for Women Undergoing Gonadotoxic Cancer Treatment.Medicina (Kaunas). 2021 Dec 8;57(12):1340. doi: 10.3390/medicina57121340. Medicina (Kaunas). 2021. PMID: 34946285 Free PMC article. Review.
-
The Increased Expression of Connexin and VEGF in Mouse Ovarian Tissue Vitrification by Follicle Stimulating Hormone.Biomed Res Int. 2015;2015:397264. doi: 10.1155/2015/397264. Epub 2015 Oct 11. Biomed Res Int. 2015. PMID: 26539488 Free PMC article.
References
-
- Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62(1):10–29. - PubMed
-
- Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011. CA Cancer J Clin. 2011;61(4):212–36. - PubMed
-
- Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin. 2003;53(1):5–26. - PubMed
-
- Siegel R, Desantis C, Virgo K, Stein K, Mariotto A, Smith T, Cooper D, Gansler T, Lerro C, Fedewa S, Lin C, Leach C, Cannady RS, Cho H, Scoppa S, Hachey M, Kirch R, Jemal A, Ward E. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012;62(4):220–41. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical